S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NYSE:DOC

Physicians Realty Trust - DOC Price Target & Analyst Ratings

$14.46
+0.12 (+0.84%)
(As of 03/28/2023 04:00 PM ET)
Add
Compare
Today's Range
$14.17
▼
$14.47
50-Day Range
$13.85
▼
$16.31
52-Week Range
$13.42
▼
$18.83
Volume
1.54 million shs
Average Volume
1.94 million shs
Market Capitalization
$3.44 billion
P/E Ratio
31.43
Dividend Yield
6.36%
Price Target
$17.96

Physicians Realty Trust Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 11 Analyst Ratings

Consensus Analyst Price Target

$17.96
24.19% Upside
High Prediction$20.00
Average Prediction$17.96
Low Prediction$14.50
TypeCurrent
3/28/22 to 3/28/23		1 Month Ago
2/26/22 to 2/26/23		3 Months Ago
12/28/21 to 12/28/22		1 Year Ago
3/28/21 to 3/28/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
1 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$17.96$18.14$18.35$19.17
Predicted Upside24.19% Upside8.30% Upside7.61% Upside7.04% Upside
Get Physicians Realty Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DOC and its competitors with MarketBeat's FREE daily newsletter.

DOC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DOC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Physicians Realty Trust Stock vs. The Competition

TypePhysicians Realty TrustFinance CompaniesS&P 500
Consensus Rating Score
2.27
2.43
2.47
Consensus RatingHoldHoldHold
Predicted Upside25.58% Upside85.03% Upside22.46% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/27/2023Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy$21.00 ➝ $19.00+32.22%
2/28/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetSector Perform$16.00 ➝ $15.00+1.28%
12/14/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeSector Weight ➝ Overweight$17.00+13.33%
11/1/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetEqual Weight$16.50 ➝ $14.50-3.72%
10/28/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$17.00+15.10%
8/22/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$19.00+7.95%
8/5/2022Colliers Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Toti
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeBuy ➝ Neutral$19.00+10.59%
7/11/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetHold$18.00 ➝ $17.00+1.80%
6/30/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy$21.00 ➝ $20.00+13.31%
6/3/2022Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		D. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageEqual Weight ➝ Equal Weight$20.00+8.93%
5/19/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeNeutral ➝ Underperform$18.00+0.56%
4/26/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOverweight$20.00+13.77%
2/1/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$19.00+4.05%
1/7/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Juan Sanabria
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ Market Perform$20.00+5.21%
8/20/2021Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Market Perform
6/14/2021Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Neutral$19.00 ➝ $20.00+2.72%
11/11/2020B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		C. Kucera
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy
4/23/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetHold$19.00 ➝ $16.00+8.92%
4/1/2020Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy
3/30/2020Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Omotayo Okusanya
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeHold
(Data available from 3/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












DOC Price Target - Frequently Asked Questions

What is Physicians Realty Trust's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Physicians Realty Trust stock is Hold based on the current 1 sell rating, 6 hold ratings and 4 buy ratings for DOC. The average twelve-month price prediction for Physicians Realty Trust is $17.96 with a high price target of $20.00 and a low price target of $14.50. Learn more on DOC's analyst rating history.

Do Wall Street analysts like Physicians Realty Trust more than its competitors?

Analysts like Physicians Realty Trust less than other Finance companies. The consensus rating score for Physicians Realty Trust is 2.27 while the average consensus rating score for finance companies is 2.43. Learn more on how DOC compares to other companies.

Does Physicians Realty Trust's stock price have much upside?

According to analysts, Physicians Realty Trust's stock has a predicted upside of 9.75% based on their 12-month price targets.

What analysts cover Physicians Realty Trust?

Physicians Realty Trust has been rated by Compass Point, and Royal Bank of Canada in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (NYSE:DOC) was last updated on 3/28/2023 by MarketBeat.com Staff